Cancer Institute A national cancer institute
designated cancer center

Calvin Kuo

Publication Details

  • beta-Catenin-Driven Cancers Require a YAP1 Transcriptional Complex for Survival and Tumorigenesis CELL Rosenbluh, J., Nijhawan, D., Cox, A. G., Li, X., Neal, J. T., Schafer, E. J., Zack, T. I., Wang, X., Tsherniak, A., Schinzel, A. C., Shao, D. D., Schumacher, S. E., Weir, B. A., Vazquez, F., Cowley, G. S., Root, D. E., Mesirov, J. P., Beroukhim, R., Kuo, C. J., Goessling, W., Hahn, W. C. 2012; 151 (7): 1457-1473

    Abstract:

    Wnt/?-catenin signaling plays a key role in the pathogenesis of colon and other cancers; emerging evidence indicates that oncogenic ?-catenin regulates several biological processes essential for cancer initiation and progression. To decipher the role of ?-catenin in transformation, we classified ?-catenin activity in 85 cancer cell lines in which we performed genome-scale loss-of-function screens and found that ?-catenin active cancers are dependent on a signaling pathway involving the transcriptional regulator YAP1. Specifically, we found that YAP1 and the transcription factor TBX5 formĀ a complex with ?-catenin. Phosphorylation of YAP1 by the tyrosine kinase YES1 leads to localization of this complex to the promoters of antiapoptotic genes, including BCL2L1 and BIRC5. A small-molecule inhibitor of YES1 impeded the proliferation of ?-catenin-dependent cancers in both cell lines and animal models. These observations define a ?-catenin-YAP1-TBX5 complex essential to the transformation and survival of ?-catenin-driven cancers.

    View details for DOI 10.1016/j.cell.2012.11.026

    View details for Web of Science ID 000312890300012

    View details for PubMedID 23245941

Stanford Medicine Resources:

Footer Links: